Post-IPO Debt - Marinus Pharmaceuticals - Mar 31, 2022 Funding Round Profile - Cointime

Bitcoin $99,121.34 +1.50%
Ethereum $3,310.78 -0.78%
BNB $623.65 +0.59%
Optimism $2.15 +0.51%
Arbitrum $0.79 -0.95%
Solana $255.86 -0.34%
Polygon $0.47 +4.85%
Cosmos $7.32 +16.13%
Avalanche $39.52 +11.36%

Bitcoin $99,121.34 +1.50%
Ethereum $3,310.78 -0.78%
BNB $623.65 +0.59%
Optimism $2.15 +0.51%
Arbitrum $0.79 -0.95%
Solana $255.86 -0.34%
Polygon $0.47 +4.85%
Cosmos $7.32 +16.13%
Avalanche $39.52 +11.36%

Marinus Pharmaceuticals

company

Funding Round

Post-IPO Debt

Money Raised

$ 30M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Oaktree Capital Management	-	Yes	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
May 17, 2021	Post-IPO Debt	$ 45M	Oaktree Capital Management	Detail
May 29, 2020	Post-IPO Equity	$ 46M		Detail
Sep 14, 2017	Post-IPO Equity	$ 40.30M	Bain Capital Life Sciences	Detail
May 3, 2009	Series B	$ 20M	Canaan Partners,Domain Associates,etc.	Detail
Jan 7, 2013	Series C	$ 21M	Canaan Partners,Domain Associates,etc.	Detail
Oct 25, 2005	Series A	$ 29.40M	Canaan Partners,Domain Associates,etc.	Detail
Dec 19, 2012	Series Unknown	$ 11.43M	RMI Partners	Detail
Dec 10, 2019	Post-IPO Equity	$ 70M	Bain Capital Life Sciences	Detail
Jul 21, 2014	IPO	$ 45M		Detail